about
Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosisMolecular cloning and characterization of a novel dual-specificity protein phosphatase possibly involved in spermatogenesisAltered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrestCdc25B functions as a novel coactivator for the steroid receptorsThe cell cycle-regulatory CDC25A phosphatase inhibits apoptosis signal-regulating kinase 1CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phaseMechanisms of G2 arrest in response to overexpression of p53Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancerThe need to accessorize: molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycleGene- and genome-based analysis of significant codon patterns in yeast, rat and mice genomes with the CUT Codon UTilization toolTransforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner.Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosisThe rhodanese/Cdc25 phosphatase superfamily. Sequence-structure-function relationsThe disappearance of cyclins A and B and the increase in activity of the G(2)/M-phase cellular kinase cdc2 in herpes simplex virus 1-infected cells require expression of the alpha22/U(S)1.5 and U(L)13 viral genes.Reovirus-induced G(2)/M cell cycle arrest requires sigma1s and occurs in the absence of apoptosis.Diallyl trisulfide-induced G2/M phase cell cycle arrest in DU145 cells is associated with delayed nuclear translocation of cyclin-dependent kinase 1.Serum-induced expression of the cdc25A gene by relief of E2F-mediated repressionE2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expressionOncogenic potential of a C.elegans cdc25 gene is demonstrated by a gain-of-function allele.The Epstein-Barr virus immediate-early protein BZLF1 induces both a G(2) and a mitotic blockTargeting the cell cycle for cancer therapy.Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cellsNeuronal cell cycle: the neuron itself and its circumstancesPectenotoxin-2 from marine sponges: a potential anti-cancer agent-a review.Plant-derived MINA-05 inhibits human prostate cancer proliferation in vitro and lymph node spread in vivoRepression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival.TGF-β1 regulates cell fate during epithelial-mesenchymal transition by upregulating survivin.Diallyl trisulfide selectively causes Bax- and Bak-mediated apoptosis in human lung cancer cells.Role of the Cdc25A phosphatase in human breast cancerCoupling morphogenesis to mitotic entry.The fermented non-digestible fraction of common bean (Phaseolus vulgaris L.) triggers cell cycle arrest and apoptosis in human colon adenocarcinoma cells.MicroRNAs dysregulated in breast cancer preferentially target key oncogenic pathways.Chk1 is activated transiently and targets Cdc25A for degradation at the Xenopus midblastula transitionIdentification of a C-terminal cdc25 sequence required for promotion of germinal vesicle breakdown.
P2860
Q21245754-D5BA970F-21C9-4852-A2D4-ED20CB67A39DQ22010889-DC3D37DE-0784-46ED-889C-067A57DDBEEAQ24537257-8035D73F-4E80-4192-B37B-A48A72351F49Q24548253-22C0EFBE-4948-45B1-972C-E8B4772B7442Q24550918-A34B7D01-21E9-4991-9AD8-5C15652E4797Q24554436-2503EE59-C699-4998-8526-BD1A8E7939F6Q24654806-C6647394-F366-4E2E-A0E6-9D354F1AC8D7Q24793291-F6C80716-84E2-48BC-9701-124BE608F724Q26864846-559074BF-CC46-4AF4-A474-552798EB0BE7Q27930810-06893E7C-DBE4-4400-86D6-98CFE30A287CQ33724405-31B6D224-2758-42F6-A676-FE47957931C0Q33756990-0638F359-AD3C-4821-B135-2F33FE7567DFQ33758088-453BC151-A876-4EB7-891A-AFE22822EEF0Q33794196-2FAC4139-0F7B-47A3-B918-0EED472F96B5Q33811605-E12B51A5-BADD-47D5-9E0D-4C444C88C279Q33862448-12927B04-9E97-4F75-B58F-298B33D96A62Q33958506-AEBCBD59-F2CD-40C8-A9E4-AFA05FA676BAQ33965671-D74D9CCE-00DC-4FBE-9019-D7A1063A39A9Q34085749-68831EA8-F363-455A-8009-EC9538985B8FQ34346421-299A8101-9B85-4105-8342-B05E2AE146C3Q34728354-7015352E-F26C-4253-B5DD-6B9C67559736Q34878214-416616B5-5D33-4569-A23F-8A6E2A067602Q35565056-04962C7A-1447-4ED3-838E-F3D017AC6C36Q35588347-1226A596-A7A5-4CB3-9824-E69EA7CCBEE9Q35756991-5CCAC8E8-4477-452F-9D9C-7FC273210C70Q35815917-D682BC3E-38C3-4995-8965-E796BA97D973Q35920356-7A8891B8-F127-4853-8C53-9B5C55CF247EQ37062041-F0D0BC64-48CF-4525-9120-7B3B8E6B7BF0Q37130622-50504F19-76FD-4ECA-8016-8BE8C5120383Q37269887-0C3F8392-0A1F-4D31-9612-B0F2D4A7AF59Q37356597-4AA7D955-BE21-45C9-ABB3-9D160A723D87Q37496638-CCC9AC7A-E77C-476B-A046-440E9A983F86Q39505211-E088D79E-160C-444D-B124-86F5FBB4E4A0Q39644973-422186CF-3F27-43CC-8D58-305DF3FF23ACQ42996464-CC543F6F-8127-4520-8C6F-128C46518EE7
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Cdc25 protein phosphatases in cell proliferation
@ast
Cdc25 protein phosphatases in cell proliferation
@en
Cdc25 protein phosphatases in cell proliferation
@nl
type
label
Cdc25 protein phosphatases in cell proliferation
@ast
Cdc25 protein phosphatases in cell proliferation
@en
Cdc25 protein phosphatases in cell proliferation
@nl
prefLabel
Cdc25 protein phosphatases in cell proliferation
@ast
Cdc25 protein phosphatases in cell proliferation
@en
Cdc25 protein phosphatases in cell proliferation
@nl
P1476
Cdc25 protein phosphatases in cell proliferation
@en
P2093
P304
P356
10.1016/S0304-419X(96)00049-2
P407
P577
1997-04-18T00:00:00Z